Skip to main content
. 2022 Jul 11;205:105381. doi: 10.1016/j.antiviral.2022.105381

Fig. 4.

Fig. 4

Confirmation of inhibition of substrate cleavage by SARS-CoV-2 3CL protease inhibitor. 0.8 μM of 3 C protein was incubated for 1 h with increasing concentration of each inhibitor separately in Tris buffer. After 1 h incubation, substrate protein was added and further incubated for 1 h, followed by SDS-PAGE analysis.